Big Changes Coming to Big Pharma

By David Williamson | More Articles
December 19, 2011 | Comments (0)

The following video is part of our "Motley Fool Conversations" series, in which, Austin Smith, consumer goods editor and analyst, and David Williamson, health-care editor and analyst, discuss topics around the investing world.

In today's edition, they discuss how Pfizer continues to shake things up. A dividend increase is on the way, and the company is looking to spin off or sell the animal health and nutrition business and use the money to bolster its pipeline -- a pipeline that needs to absorb the loss of the worlds best selling drug Lipitor.

Editor's note: Since the filiming of this video, Pfizer has increased its dividend.

Looking for our prediction for 2012? Check out The Motley Fool's brand new report, "The Motley Fool's Top Stock for 2012." It highlights a company that is revolutionizing commerce in Latin America. You can get instant access to the name of this company by clicking here -- it's free. It won't be there forever, so check it out today.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Austin Smith and David Williamson both own shares of Pfizer. The Motley Fool owns shares of Abbott Laboratories. Motley Fool newsletter services have recommended buying shares of Pfizer and Abbott Laboratories. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (8)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 1745207, ~/Articles/ArticleHandler.aspx, 5/27/2012 4:58:52 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
	DOW	12,454.83	-74.92	-0.60%
	S&P 500	1,317.82	-2.86	-0.22%
	NASD	2,837.53	-1.85	-0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Most Popular Articles

in the last seven days

Related Tickers

5/25/2012 4:00 PM

PFE	$22.13		-0.01	-0.05%
Pfizer, Inc.		CAPS Rating:

MJN	$83.02		+0.83	+1.01%
Mead Johnson Nutri…		CAPS Rating:

WAG	$31.36		+0.10	+0.32%
Walgreen Company		CAPS Rating:

WPI	$72.67		-0.09	-0.12%
Watson Pharmaceuti…		CAPS Rating:

ABT	$62.25		-0.17	-0.27%
Abbott Laboratorie…		CAPS Rating:

BMY	$33.09		+0.10	+0.30%
Bristol-Myers Squi…		CAPS Rating:

CVS	$44.98		-0.19	-0.42%
CVS Caremark Corp		CAPS Rating: